Imaging Synaptic Density in Aging and Alzheimer Disease with [ 18 F]SynVesT-1
Journal of Nuclear Medicine · 2025-04 · 66 (4) · 620-625
DOI: 10.2967/jnumed.124.269005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 06.03.2025. Verfasst von Joseph Giorgio und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, University of California Berkeley, Berkeley, California; jgiorgio@berkeley.edu. Hauptthemen laut MEDLINE: Alzheimer Disease, Positron-Emission Tomography, Aging, Synapses. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Synaptic density imaging with PET is a relatively new approach to monitoring synaptic injury in neurodegenerative diseases. However, there are remaining technical and clinical questions, including questions on reference region selection and on how specific phenotypic presentations and symptoms of Alzheimer disease (AD) are reflected in alterations in synaptic density.
Methods
Using a synaptic vesicle glycoprotein 2A (SV2A) PET ligand radiolabeled with the 18F isotope ([18F]SynVesT-1), we performed sensitivity analyses to determine the optimal reference tissue modeling approach to derive whole-brain ratio images. Using these whole-brain images from a sample of young adults, older adults, and patients with varied phenotypic presentations of AD, we then contrasted regional SV2A density and in vivo AD biomarkers.
Results
Reference tissue optimization concluded that a cerebellar gray matter reference region is best for deriving whole-brain ratio images. Using these images, we found a strong inverse association between [18F]SynVesT-1 PET uptake and amyloid β and tau PET deposition. Finally, we found that individuals with a lower temporal gray matter volume but higher temporal [18F]SynVesT-1 PET uptake show preserved performance on the mini-mental state examination. Conclusion: [18F]SynVesT-1 PET shows a close association with in vivo AD pathology, and preserved SV2A density may be a possible marker for resilience to neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, University of California Berkeley, Berkeley, California; jgiorgio@berkeley.edu.
- School of Psychological Sciences, College of Engineering, Science, and the Environment, University of Newcastle, Newcastle, New South Wales, Australia.
- Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California.
- Lawrence Berkeley National Laboratory, Berkeley, California.
- Department of Neuroscience, University of California Berkeley, Berkeley, California.
- Department of Psychology, Stony Brook University, Stony Brook, New York.
Förderung
- NIA NIH HHS
Zitieren
APA
Giorgio, J., Soleimani-Meigooni, D. N., Janabi, M., Baker, S. L., Chen, X., Toueg, T. N., Weimer, R., Zinnhardt, B., Green, A., Rabinovici, G. D., & Jagust, W. J. (2025). Imaging Synaptic Density in Aging and Alzheimer Disease with [ 18 F]SynVesT-1. Journal of Nuclear Medicine, 66(4), 620-625. https://doi.org/10.2967/jnumed.124.269005
Vancouver
Giorgio J, Soleimani-Meigooni DN, Janabi M, Baker SL, Chen X, Toueg TN, et al. Imaging Synaptic Density in Aging and Alzheimer Disease with [ 18 F]SynVesT-1. Journal of Nuclear Medicine. 2025;66(4):620-625. doi:10.2967/jnumed.124.269005
BibTeX
@article{Giorgio2025,
author = {Giorgio, Joseph and Soleimani-Meigooni, David N and Janabi, Mustafa and Baker, Suzanne L and Chen, Xi and Toueg, Tyler N and Weimer, Robby and Zinnhardt, Bastian and Green, Ari and Rabinovici, Gil D and Jagust, William J},
title = {Imaging Synaptic Density in Aging and Alzheimer Disease with [ 18 F]SynVesT-1},
journal = {Journal of Nuclear Medicine},
year = {2025},
volume = {66},
number = {4},
pages = {620--625},
doi = {10.2967/jnumed.124.269005}
}
EUVIMED